Skip to main content
SP5007,781.09-0.23%DOW53,711.34-0.24%NASDAQ26,682.43-0.45%BTC$63,101.000.00%ETH$1,883.21+0.52%GOLD$4,444.30+0.54%OIL$81.81+0.69%
Smart Investors Daily
Sign InSign Up Free
NV

NASDAQ · NVACR

NorthView Acquisition Corporation

Financial Services · Shell Companies

$0.23

Up+$0.06 (+35.35%)

Updated Aug 14, 2026, 4:50 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
78.44M
P/E ratio
-0.14
Dividend yield
0.00%
52-week range
— – —
Volume
1.34M
Avg. volume
32.53K

Price performance

NVACR price history

1M range · 0 trading sessions · Daily adjusted prices

NVACR does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest NVACR news

The latest Smart Investors Daily articles mentioning NVACR.

Stock researchCompany · Overview

NVACR research

Overview

Company profile and research snapshot.

Company profile

NorthView Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus its search on target businesses in the healthcare sector. The company was incorporated 2021 and is based in New York, New York. NorthView Acquisition Corporation operates as a subsidiary of NorthView Sponsor I, LLC.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Dec 26, 2024

NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Failure to Complete Initial Business Combination

NorthView Acquisition Corporation has received a notice from Nasdaq indicating that its securities will be delisted due to its failure to complete an initial business combination within the required 36-month timeframe. The company intends to apply for listing on the OTC market, and the planned business combination with Profusa Inc. is still ongoing.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By